05-15-2018 07:36 AM CET - Health & Medicine
Print

Tumor Ablation Market Forecast 2024 Global Key Players Galil Medical Inc., Perseon Corporation, NeuWave Medical, Inc., Koninklijke Philips N.V., Medtronic

Press release from: Data Bridge Market Research

"Tumor Ablation Market"
Global Tumor Ablation market By Type (Tumor Ablation Systems {Radio Frequency Ablation System, Microwave Ablation System, Cryoablation, High Intensity Focused Ultrasound , Laser Ablation System}, Image Guidance Products, Accessories), By Cancer Type (Liver Cancer, Brain Cancer, Lung Cancer, Bone Cancer, Kidney Cancer, Pancreatic Cancer, Breast Cancer, Others), By Mode of Treatment (Surgical, Laparoscopic, Percutaneous), By End User (Hospitals, Oncology Clinics, Others), By Region (North America, Europe, Asia Pacific, South America, Middle East and Africa) and Forecast to 2024.

Get Free Sample Report @ databridgemarketresearch.com/request-a-sample/?dbmr=globa...

Global Tumor Ablation Market is expected to reach USD 3,495.0 million by 2024 from USD 1,669.7 million in 2016, at a CAGR of 9.8% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

The major factors contributing to the growth of the market includes incidences of cancer patients, increase in the number of hospitals, ablation and surgical centers, technological advancement in ablation devices. On the other hand, stringent regulatory process would restrain the growth of the market.

Market Segmentation: Global Tumor Ablation Market

The global tumor ablation market is segmented on the basis of type, cancer type, mode of treatment, end user, and geography. On the basis of type, the market is segmented into three major segments which include tumor ablation systems, image guidance products, and accessories. In 2017, the Tumor Ablation Systems market segment is expected to dominate the market with 69.2%. Tumor Ablation Systems is further sub segmented into radio frequency ablation system (RFA), microwave ablation system, cryoablation, high intensity focused ultrasound and laser ablation system. In 2017, radio frequency ablation system (RFA) market segment is expected to dominate the market with 53.8%.

On the basis of cancer type, the market is segmented into eight major segments which include liver cancer, brain cancer, lung cancer, bone cancer, kidney cancer, pancreatic cancer, breast cancer and others, The lung cancer market is expected to grow at the highest CAGR 10.7% in the forecast period of 2017 to 2024.

Based on mode of treatment, the global tumor ablation market is segmented into surgical, laproscopic and percutaneous. The Surgical is projected to witness higher growth during the forecast period., The laparoscopic market is expected to grow at the highest CAGR 10.8% in the forecast period of 2017 to 2024.

On the basis of end users, the market is segmented into hospital, oncology clinics, and others. In 2017, the hospital market segment is expected to dominate the market. with a share of 68.3%.

Based on geography, the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa.

For Any Query Speak to Expert @ databridgemarketresearch.com/speak-to-analyst/?dbmr=globa...

Key Drivers: Global Tumor Ablation Market

Some of the major factors driving the market for global tumor ablation market are increasing incidences of cancer patients, increase in the number of hospitals, ablation and surgical centers, technological advancement in ablation devices. These factors increase the demand for devices such as tumor ablation systems and image guidance products.

High treatment cost and side effects associated with ablation treatment may hinder the growth of this market.

According to American Cancer Society, in 2017, approximately 1,688,780 new cancer cases were diagnosed and 600,920 cancer deaths were reported in the US.

Many companies are increasingly focusing on technological advancement of devices in order to strengthen their product portfolios in the tumor ablation market.

Key Points: Global Tumor Ablation Market

Medtronic is going to dominate the global tumor ablation market following with, Boston Scientific Corporation and Abbott along with others such as Galil Medical Inc., Perseon Corporation, NeuWave Medical, Inc., Koninklijke Philips N.V., INTIO Inc., Mermaid Medical A/S, SonaCare Medical, LLC, DFINE, Inc., Misonix, BVM Medical Limited, AngioDynamics, COMSOL Inc, EDAP TMS, and HealthTronics, Inc.

In 2017, the tumor ablation systems segment is expected to account for the largest share of 69.2% of the global tumor ablation market, by type. This segment is expected to grow at the highest CAGR of 10.2% in the forecast period 2017 to 2024.

Radio frequency ablation system segment is going to dominate the tumor ablation market owing to effective treatment for small cancers, minimal risk to patient, and faster results will drive the growth of the market.

View Full Report @ databridgemarketresearch.com/reports/global-tumour-ablati...

Table of Contents:

1. INTRODUCTION

1.1. OBJECTIVES OF THE STUDY
1.2. MARKET DEFINITION
1.3. MARKET SCOPE
1.4. OVERVIEW OF GLOBAL TUMOR ABLATION MARKET
1.5. CURRENCY AND PRICING
1.6. LIMITATION
1.7. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCE
2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS

3.1.1. INCREASING PREVALENCE OF CANCER PATIENTS
3.1.2. TECHNOLOGICAL ADVANCEMENTS IN ABLATION DEVICES
3.1.3. RISING NUMBER OF HOSPITALS, SURGICAL, AND ABLATION CENTERS

3.2. RESTRAINTS

3.2.1. HIGH COST OF TUMOR ABLATION TREATMENT
3.2.2. SIDE EFFECTS ASSOCIATED WITH ABLATION TREATMENT
3.2.3. SHORTAGE OF SKILLED AND TRAINED PROFESSIONALS

3.3. OPPORTUNITIES

3.3.1. GROWTH POTENTIAL OFFERED BY DEVELOPING MARKETS
3.3.2. GROWING AWARENESS ABOUT ABLATION PROCEDURES

3.4. CHALLENGES

3.4.1. STRINGENT REGULATORY GUIDELINES

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. GLOBAL TUMOR ABLATION MARKET, BY TYPE

6.1. OVERVIEW

6.2. TUMOR ABLATION SYSTEMS

6.2.1. RADIOFREQUENCY ABLATION SYSTEM (RFA)
6.2.2. MICROWAVE ABLATION SYSTEM
6.2.3. HIGH FREQUENCY FOCUSED ULTRASOUND ABLATION SYSTEM (HIFU)
6.2.4. LASER ABLATION SYSTEM
6.2.5. CRYOABLATION

6.3. IMAGE GUIDANCE PRODUCTS

6.4. ACCESSORIES

7. GLOBAL TUMOR ABLATION MARKET, BY CANCER TYPE

7.1. OVERVIEW
7.2. LIVER CANCER
7.3. BRAIN CANCER
7.4. LUNG CANCER
7.5. BONE CANCER
7.6. KIDNEY CANCER
7.7. PANCREATIC CANCER
7.8. BREAST CANCER
7.9. OTHERS

8. GLOBAL TUMOR ABLATION MARKET, BY MODE OF TREATMENT

8.1. OVERVIEW
8.2. SURGICAL
8.3. LAPAROSCOPIC
8.4. PERCUTANEOUS

9. GLOBAL TUMOR ABLATION MARKET, BY END USER

9.1. OVERVIEW
9.2. HOSPITALS
9.3. ONCOLOGY CLINICS
9.4. OTHERS

10. GLOBAL TUMOR ABLATION MARKET, BY GEOGRAPHY

10.1. OVERVIEW
10.2. NORTH AMERICA
10.3. EUROPE
10.4. ASIA-PACIFIC
10.5. SOUTH AMERICA
10.6. MIDDLE EAST AND AFRICA

11. GLOBAL TUMOR ABLATION MARKET, COMPANY LANDSCAPE

11.1. COMPANY SHARE ANALYSIS: GLOBAL
11.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
11.3. COMPANY SHARE ANALYSIS: EUROPE
11.4. COMPANY SHARE ANALYSIS: ASIA-PACIFIC

12. COMPANY PROFILES

1.1. MEDTRONIC

1.1.1. COMPANY OVERVIEW
1.1.2. MEDTRONIC :REVENUE ANALYSIS
1.1.3. PRODUCT PORTFOLIO
1.1.4. RECENT DEVELOPMENTS

1.2. STRYKER

1.2.1. COMPANY OVERVIEW
1.2.2. STRYKER :REVENUE ANALYSIS
1.2.3. PRODUCT PORTFOLIO
1.2.4. RECENT DEVELOPMENTS

1.3. TERUMO CORPORATION

1.3.1. COMPANY OVERVIEW
1.3.2. TERUMO CORPORATION :REVENUE ANALYSIS
1.3.3. PRODUCT PORTFOLIO
1.3.4. RECENT DEVELOPMENTS

1.4. INTEGRA LIFESCIENCES CORPORATION

1.4.1. COMPANY OVERVIEW
1.4.2. INTEGRA LIFESCIENCES CORPORATION : REVENUE ANALYSIS
1.4.3. PRODUCT PORTFOLIO
1.4.4. RECENT DEVELOPMENTS

1.5. KONINKLIJKE PHILIPS N.V.

1.5.1. COMPANY OVERVIEW
1.5.2. KONINKLIJKE PHILIPS N.V.: REVENUE ANALYSIS
1.5.3. PRODUCT PORTFOLIO
1.5.4. RECENT DEVELOPMENTS

1.6. NEUWAVE MEDICAL, INC (ACQUIRED BY ETHICON US, LLC, SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)

1.6.1. COMPANY OVERVIEW
1.6.2. JOHNSON & JOHNSON SERVICES, INC.:REVENUE ANALYSIS
1.6.3. PRODUCT PORTFOLIO
1.6.4. RECENT DEVELOPMENTS

1.7. BOSTON SCIENTIFIC CORPORATION

1.7.1. COMPANY OVERVIEW
1.7.2. BOSTON SCIENTIFIC CORPORATION :REVENUE ANALYSIS
1.7.3. PRODUCT PORTFOLIO
1.7.4. RECENT DEVELOPMENTS

1.8. MERMAID MEDICAL A/S

1.8.1. COMPANY OVERVIEW
1.8.2. MERMAID MEDICAL A/S: COMPANY SNAPSHOT
1.8.3. PRODUCT PORTFOLIO
1.8.4. RECENT DEVELOPMENTS

1.9. SONACARE MEDICAL, LLC

1.9.1. COMPANY OVERVIEW
1.9.2. SONACARE MEDICAL, LLC.: COMPANY SNAPSHOT
1.9.3. PRODUCT PORTFOLIO
1.9.4. RECENT DEVELOPMENTS

1.10. MERIT MEDICAL SYSTEMS, INC

1.10.1. COMPANY OVERVIEW
1.10.2. MERIT MEDICAL SYSTEMS, INC.:REVENUE ANALYSIS
1.10.3. PRODUCT PORTFOLIO
1.10.4. RECENT DEVELOPMENTS

1.11. BVM MEDICAL LIMITED

1.11.1. COMPANY OVERVIEW
1.11.2. BVM MEDICAL LIMITED : COMPANY SNAPSHOT
1.11.3. PRODUCT PORTFOLIO
1.11.4. RECENT DEVELOPMENTS

1.12. INSIGHTEC LTD

1.12.1. COMPANY OVERVIEW
1.12.2. INSIGHTEC LTD :COMPANY SNAPSHOT
1.12.3. PRODUCT PORTFOLIO
1.12.4. RECENT DEVELOPMENTS

1.13. ABBOTT

1.13.1. COMPANY OVERVIEW
1.13.2. ABBOTT:REVENUE ANALYSIS
1.13.3. PRODUCT PORTFOLIO
1.13.4. RECENT DEVELOPMENTS

1.14. VYTRONUS, INC

1.14.1. COMPANY OVERVIEW
1.14.2. VYTRONUS, INC : COMPANY SNAPSHOT
1.14.3. PRODUCT PORTFOLIO
1.14.4. RECENT DEVELOPMENTS

1.15. BALYIS MEDICAL

1.15.1. COMPANY OVERVIEW
1.15.2. BAYLIS MEDICAL : COMPANY SNAPSHOT
1.15.3. PRODUCT PORTFOLIO
1.15.4. RECENT DEVELOPMENTS

1.16. EDAP TMS

1.16.1. COMPANY OVERVIEW
1.16.2. REVENUE ANALYSIS
1.16.3. PRODUCT PORTFOLIO
1.16.4. RECENT DEVELOPMENTS

1.17. ATRICURE, INC.

1.17.1. COMPANY OVERVIEW
1.17.2. REVENUE ANALYSIS
1.17.3. PRODUCT PORTFOLIO
1.17.4. RECENT DEVELOPMENTS

1.18. FCARE SYSTEMS

1.18.1. COMPANY OVERVIEW
1.18.2. FCARE SYSTEMS: COMPANY SNAPSHOT
1.18.3. PRODUCT PORTFOLIO
1.18.4. RECENT DEVELOPMENTS

1.19. ECO, INC.

1.19.1. COMPANY OVERVIEW
1.19.2. ECO INC. : COMPANY SNAPSHOT
1.19.3. PRODUCT PORTFOLIO
1.19.4. RECENT DEVELOPMENTS

1.20. NONINVASIVE MEDICAL DEVICES, LTD.

1.20.1. COMPANY OVERVIEW
1.20.2. NONINVASIVE MEDICAL DEVICES, LT. : COMPANY SNAPSHOT
1.20.3. PRODUCT PORTFOLIO
1.20.4. RECENT DEVELOPMENTS

Related Report

Global Ablation Devices Market – Trends and Forecast to 2024

Global Ablation Devices Market, By Technology (Electrical, Radiation, Radiofrequency, Light, Ultrasound, Cryotherapy, Thermal, Microwave, Hydro-mechanical), By Application (Cancer, Cardiovascular, Orthopedics, Urology, Gynecology, Ophthalmology and Others), By Geography (North America, Europe, Asia-Pacific, Latin America, Rest of the World) – Trends and Forecast to 2024

Report Access: databridgemarketresearch.com/reports/global-ablation-devi...

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.
News-ID: 1049548 • Views: 185
More releasesMore releases

You can edit or delete your press release here: